A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal☆ - Concepedia

Concepedia

Publication | Open Access

A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal☆

DOI Full Paper Access

61

Citations

28

References

2008

Year

Elmer Yu, Karen Miotto, Evaristo Akerele, Ann Elizabeth Montgomery, Ahmed Elkashef, Robert Walsh, Iván D. Montoya, Marian W. Fischman, Joseph Collins, Frances McSherry

Drug and Alcohol Dependence

Phase 3AddictionMedicineNeuropharmacologyOpioid Withdrawal☆PharmacotherapyOpioid OverdosePharmacologyMulti-site TrialOpioid Use DisorderAnesthesiologyHealth Sciences

References

	Year	Citations

Page 1

Page 1